Singapore and Hong Kong ink MoU on health product regulation

The agreement covers pharmaceuticals, medical devices, and traditional medicine.

Singapore's Health Sciences Authority (HSA) and Hong Kong’s Department of Health (DoH) have signed a memorandum of understanding (MoU) to cooperate on regulatory matters concerning health products.

The agreement covers technical cooperation and the exchange of information, best practices, and expertise across products such as pharmaceuticals, medical devices, therapy products, and traditional medicines.

The MoU also includes the sharing of regulatory information and enforcement approaches for tobacco products and vaping devices.

Moreover, it enables exchange of regulatory experts and staff, participation in meetings and scientific conferences, and collaboration in training courses and joint projects.

The MoU was signed by HSA CEO, Raymond Chua and the Director of Health, Hong Kong DoH, Ronald Lam.